Alzheimer Disease: all 3,765 studies
Page 32 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient CareCompletedNCT01639586Not applicable
- Multi-modal Neuroimaging in Alzheimer's Disease IMAP+CompletedNCT01638949Not applicable
- Prospective Memory ImagingStatus unknownNCT01638884Not applicable
- Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's DiseaseWithdrawnNCT01636596Not applicable
- " The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's DiseaseCompletedNCT01630525
- Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot StudyStatus unknownNCT01624389Not applicable
- A Composite MR Neuroimaging Marker for Alzheimer's DiseaseWithdrawnNCT01615666
- Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young AdultsCompletedNCT01609335Phase 1
- Delta-THC in DementiaCompletedNCT01608217Phase 2
- Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Prolonged Open Label Extension PhaseCompletedNCT01602393Phase 2
- Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)CompletedNCT01600859Phase 1
- NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's DiseaseCompletedNCT01600469Phase 2
- Multicenter Vitamin E Trial in Aging Persons With Down SyndromeCompletedNCT01594346Phase 3
- A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker DiscoveryCompletedNCT01592552
- Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population StudyCompletedNCT01582919Not applicable
- Oculomotor Testing in the Differential Diagnosis of DementiaCompletedNCT01577394Phase 3
- Blood-brain Barrier Permeability in Alzheimer's DiseaseCompletedNCT01574456
- Determinants of Quality of Life Related to Health in Alzheimer DiseaseStatus unknownNCT01570322
- Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's DiseaseStatus unknownNCT01569516Phase 2
- Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AD03 Applied During AFF005ATerminatedNCT01568086
- Ability to Drive of Early Stage Alzheimer DiseaseCompletedNCT01566071Not applicable
- Erythrocyte Complement Receptor 1 and Alzheimer DiseaseCompletedNCT01565434Not applicable
- Deep Brain Stimulation for the Treatment of Alzheimer's DiseaseCompletedNCT01559220Not applicable
- Retinal Neurodegenerative Signs in Alzheimer's DiseasesCompletedNCT01555827Not applicable
- Multi-modal Neuroimaging in Alzheimer's DiseaseStatus unknownNCT01554202Not applicable
- Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) PatientTerminatedNCT01553929Not applicable
- Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsCompletedNCT01549834Phase 2
- A Safety Study of TTP4000 in Subjects With Alzheimer's DiseaseCompletedNCT01548430Phase 1
- The Primary Care - Dementia Assessment and Treatment AlgorithmCompletedNCT01548053Not applicable
- Safety and Efficiency of Umbilical Cord-derived Mesenchymal Stem Cells(UC-MSC) in Patients With Alzheimer's DiseaseStatus unknownNCT01547689Phase 1/2
- Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 DaysCompletedNCT01547169Phase 2
- Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's DiseaseCompletedNCT01539031Phase 3
- Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's DiseaseCompletedNCT01538212
- A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])CompletedNCT01537757Phase 1
- Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase InhibitorsCompletedNCT01529619Phase 4
- Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT01527916Phase 2
- Physical Exercise as an Additional Treatment for Alzheimer DiseaseCompletedNCT01515982Not applicable
- Mirtazapine in Alzheimer-associated Weight LossCompletedNCT01505504
- A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)CompletedNCT01503944Phase 1/2
- Inherited Diseases, Caregiving, and Social NetworksCompletedNCT01498263
- A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants With Alzheimer's Disease (MK-8931-010 AM1 [P07820 AM1])CompletedNCT01496170Phase 1
- Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's DiseaseCompletedNCT01492374Phase 1
- Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical DevelopmentCompletedNCT01487395Phase 1
- Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's PatientsCompletedNCT01485302Phase 1
- A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's DiseaseCompletedNCT01482845Phase 1
- Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's DiseaseTerminatedNCT01482013Phase 1
- Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's DiseaseCompletedNCT01481961Not applicable
- Multiple Nutritional Deficiencies Causing Dementia of the Alzheimer TypeStatus unknownNCT01479855
- Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From DonepezilCompletedNCT01478633Phase 4
- A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT01478204
- EEG Objectification in NeuropsychiatryStatus unknownNCT01476228Not applicable
- Identifying Potential Effects of Liraglutide on Degenerative ChangesCompletedNCT01469351Not applicable
- Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly SubjectsCompletedNCT01467726Phase 1
- Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)CompletedNCT01466088Phase 2
- Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory CenterCompletedNCT01465360
- Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy ControlsCompletedNCT01461109Phase 1
- Optimisation of Antipsychotic Drug Use in Older PeopleTerminatedNCT01454453Phase 4
- Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163CompletedNCT01454115Phase 1
- Health Technology Assessment of Diagnostic Approaches in Alzheimer's DiseaseCompletedNCT01450891
- A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's DiseaseCompletedNCT01436188Early Phase 1
- Using Hypnotherapy For Dementia & Alzheimer'sNo longer availableNCT01435551
- Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/DepressionStatus unknownNCT01434940Not applicable
- Web-based Psycho-Educational Program to Support Carers of Alzheimer's PatientsCompletedNCT01430286Not applicable
- VI-1121 for the Treatment Alzheimer's DiseaseCompletedNCT01428362Phase 2
- Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease PatientCompletedNCT01424436Phase 1
- Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's DiseaseCompletedNCT01423396Not applicable
- Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074 and Exploration of Effects on Potential Markers of Clinical Efficacy in Patients With Mild Cognitive Impairment - Open Label Extension (CT04 OLEP)CompletedNCT01421056Phase 2
- The Prevalence of Vitamin D Deficiency in Patients With Alzheimer's DiseaseCompletedNCT01420315
- Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention TrialStatus unknownNCT01417130
- Alzheimer's Disease - Input of Vitamin D With mEmantine AssayCompletedNCT01409694Phase 3
- A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of DonepezilCompletedNCT01406145Phase 1
- A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's DiseaseCompletedNCT01404169Phase 3
- Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and PersonalizedStatus unknownNCT01403519
- Sleep Apnea in Early to Mid-Stage Alzheimer's DiseaseTerminatedNCT01400542
- A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT01397578Phase 2
- Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's DiseaseCompletedNCT01397539Phase 1
- Ecological Assessment of Apathy in Alzheimer's Disease and in Control Subjects: Video Recognition and ActigraphyCompletedNCT01384344Not applicable
- Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After RivastigmineCompletedNCT01380288Not applicable
- Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism InvestigationStatus unknownNCT01378026
- NAC-003 P.L.U.S. Program (Progress Through Learning Understanding & Support)CompletedNCT01370954
- PRISM Registry: Pseudobulbar Affect Registry SeriesCompletedNCT01366027
- Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's DiseaseTerminatedNCT01357629
- Cytokines and Cognitive Decline in Alzheimer's DiseaseCompletedNCT01351142Not applicable
- Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease PatientsCompletedNCT01350362Phase 2
- Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy VolunteersCompletedNCT01348737Phase 1
- Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and ControlsCompletedNCT01348061
- A Longitudinal Multidimensional Population Study on Brain AgingCompletedNCT01345110
- A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)CompletedNCT01343966Phase 2
- Post-stroke Cognitive Impairment and DementiaCompletedNCT01339195Not applicable
- Assessment of Social-emotional Functioning in Neurological DiseasesCompletedNCT01339130Not applicable
- Transcranial Magnetic Stimulation (TMS) Treatment for Alzheimer PatientsCompletedNCT01334450Phase 2
- Study of Factors Influencing Post-stroke DementiaCompletedNCT01330160
- Effect of Cognitive Intervention in Alzheimer's Disease (AD) on Functional Cortical Networks in fMRIStatus unknownNCT01329601Phase 4
- The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's DiseaseCompletedNCT01329536
- Computerized Personal Interventions for Alzheimer's PatientsStatus unknownNCT01329484Not applicable
- A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)CompletedNCT01325662
- An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's DiseaseCompletedNCT01325402Phase 1
- FluoroAv45 Imaging Research-in Alzheimer's DiseaseCompletedNCT01325259Phase 2
- Research on Aging Project in Iceland: Second StageCompletedNCT01322568
- A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ TestStatus unknownNCT01322373